Skip to main content

Diabetes patients, Intarcia Therapeutics has great news for you

intarcia releases impressive diabetes clinical trial results screen shot 2015 08 22 at 9 59 03 pm
Image used with permission by copyright holder
Diabetes patients, one matchstick-sized implant may soon change your life forever, and its name is Intarcia. Following incredibly promising clinical trial results that pitted Boston based startup’s Intarcia Therapeutics against Merck’s Januvia, the current leading medication on the market for those with Type 2 diabetes, the new kid on the block is proving its mettle. According to its latest press release, Intarcia actually outperformed Januvia when tested in 535 patients, with nearly double the success in terms of glucose reduction and triple the weight loss results. And most interesting of all, unlike Januvia, which is taken orally on a daily basis, Intarcia’s high-tech approach actually employs an osmotic pump that constantly delivers small amounts of a drug over the course of the year, meaning patients don’t have to worry about forgetting to take their pills.

Currently, Merck’s Januvia maintains a firm hold on market share of the Type 2 diabetes medication landscape, reporting some $6 billion in global sales in 2014. But now, with the proven effectiveness of Intarcia, along with the more convenient method of consumption, Merck may be forced to loosen its grip. To implant the matchstick sized device takes approximately one minute in an out-patient procedure, and because it consistently sends predetermined quantities of medication throughout the body, it helps maintain a sense of equilibrium for the patient, which is key for diabetics.

Today, around 29 million Americans suffer from diabetes, with hundreds of millions more worldwide. Unfortunately, fewer than half of the patients in the U.S. manage to control their blood sugar, largely because they forget to take their medication, or do so sporadically. Anne Peters, a professor of medicine at the Keck School of Medicine at University of Southern California, told The Wall Street Journal, “It’s unbelievable how hard it is to make people stay on a chronic medication, especially when they don’t feel sick.” This makes Intarcia a particularly attractive choice.

Of course, Merck remains self-assured that its own drug will not be bested by the newcomer. Said a spokeswoman for the pharmaceutical giant, “We are confident that physicians will continue to choose Januvia, the world’s leading branded oral diabetes medicine, to help a broad range of patients with Type 2 diabetes.” But if Intarcia turns out to be as effective as it claims to be, then it may be giving Januvia a serious run for its money.

Editors' Recommendations

Lulu Chang
Former Digital Trends Contributor
Fascinated by the effects of technology on human interaction, Lulu believes that if her parents can use your new app…
ClipDart is an on-demand barber app aimed at people of color
ClipDart founder, Kyle Parker.

It’s funny how we can take certain things for granted, like haircuts. Over the course of more than 50 years of living in different cities, different neighborhoods, or even visiting different countries, not once have I ever worried about whether I could find someone who could cut my hair the way I liked. Then again, I’m white.

But if you’re a person of color, it can be an entirely different experience. That’s what Kyle Parker discovered when he left his hometown of Chicago in 2013 to attend Grinnell College in Grinnell, Iowa, population 9,031. While 24% of Grinnell College’s students identify themselves as people of color, fewer than 10% of residents of the city of Grinnell would say the same of themselves.

Read more
Circular confirms its $259 smart ring is coming to the U.S.
best wearables of ces 2022 circular ring

The Circular smart ring is finally going to be available for pre-order on Sunday, February 27, via the Circular website and will cost $259. The wearable tech will be available for presale in European countries (France, Germany, the U.K., and Italy,) the United States, Australia, Hong Kong, and Singapore. Pre-orders will go live at 1:30 p.m. ET on Sunday, February 27. Those who pre-order the smart ring should expect delivery between April and June 2022, according to a Circular press release.

Circular doesn't clarify what ring sizes will be available when presales go live, however, the company has said that seven sizes for both men and women will be available. Digital Trends has reached out for clarification on the available sizes, and will update this article when we hear back. The Circular smart ring also comes in four different colors that can be switched out with replaceable outer shells: Black, rose gold, silver, and gold.

Read more
How to take an ECG with your Apple Watch and see irregular heart notifications
ecg app apple watch

The ECG app is one of the most vital features of the Apple Watch, allowing you to see an electrocardiogram of your heart whenever you want. Along with this, the Apple Watch can notify you of irregular heart rhythms.

Read more